SI-BONE, Inc.
NASDAQ: SIBN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Laura A. Francis
- Employees
- 349
- Headquarters
- Santa Clara, United States
- IPO year
- 2018
- Market cap
- $724.7M
- Website
- https://si-bone.com
Loading SIBN…
Loading profile data…Frequently asked questions about SIBN
What does SI-BONE, Inc. (SIBN) do?
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a rang...
Where does SIBN trade?
SI-BONE, Inc. (SIBN) trades on the NASDAQ Global Market.
What sector is SIBN in?
SI-BONE, Inc. (SIBN) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of SI-BONE, Inc.?
Laura A. Francis is the chief executive officer of SI-BONE, Inc. (SIBN).
Where is SI-BONE, Inc. headquartered?
SI-BONE, Inc. is headquartered in United States.
Does SIBN pay a dividend?
SI-BONE, Inc. (SIBN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SIBN go public?
SI-BONE, Inc. (SIBN) completed its initial public offering in 2018.